Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report
- PMID: 21054590
- DOI: 10.1111/j.1365-2303.2010.00814.x
Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report
Abstract
Background: Oral squamous cell carcinoma (OSCC) is the sixth most common cancer. The local recurrence of OSSC might result from the existence of occult cancer cells around tumour margins. Exfoliative cytology has lately gained great importance as a method for obtaining RNA samples from suspicious oral mucosal lesions in order to carry out molecular diagnosis. In addition, melanoma associated-A antigens (MAGE-A) are expressed in various tumours and their detection is a highly accurate sign that cancer cells are present.
Objective: The prediction of a recurrence using MAGE-A mRNA expression analysis to follow-up OSCC cases using a newly established molecular diagnostic technique applied to cytological materials.
Methods: RNA was extracted from three recurrent OSCC cases and from 20 healthy volunteers as a control group using a cytobrush. The expression of MAGE-A3, A4, A6, A10 and A12 was investigated in these specimens using quantitative real-time (RT-PCR).
Results: There was no expression of MAGE-A in the specimens of normal oral mucosa. However, the expression analysis of five different MAGE-A genes indicated a high potential for malignant change in biopsy-proven recurrent OSCC cases. Except for MAGE-A10, the rest of the genes were expressed in different ratios by the three recurrent cases, which had been determined on histopathology to be OSCC or carcinoma in situ.
Conclusion: It is suggested that analysis of MAGE-A expression may be used as a risk prediction method in the diagnosis of recurrence after wide excision of OSCC to enhance the accuracy of exfoliative cytology, which has limitations due to false negative and false positive results.
© 2010 Blackwell Publishing Ltd.
Similar articles
-
Expression of melanoma-associated antigens in oral squamous cell carcinoma.J Oral Pathol Med. 2008 Feb;37(2):88-93. doi: 10.1111/j.1600-0714.2007.00600.x. J Oral Pathol Med. 2008. PMID: 18197853
-
Evaluation of MAGE A1 in oral squamous cell carcinoma.Oncol Rep. 2012 Jun;27(6):1843-8. doi: 10.3892/or.2012.1736. Epub 2012 Mar 19. Oncol Rep. 2012. PMID: 22447174
-
Intraoperative imprint evaluation of surgical margins in oral squamous cell carcinoma.Acta Cytol. 2013;57(1):75-83. doi: 10.1159/000342916. Epub 2012 Dec 6. Acta Cytol. 2013. PMID: 23221361
-
Potential biomarkers in saliva for oral squamous cell carcinoma.Oral Oncol. 2010 Apr;46(4):226-31. doi: 10.1016/j.oraloncology.2010.01.007. Epub 2010 Feb 6. Oral Oncol. 2010. PMID: 20138569 Review.
-
[Usefulness of oral exfoliative cytology for the diagnosis of oral squamous dysplasia and carcinoma].Minerva Stomatol. 2004 Mar;53(3):77-86. Minerva Stomatol. 2004. PMID: 15107778 Review. Italian.
Cited by
-
MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes.Int J Clin Oncol. 2016 Oct;21(5):875-882. doi: 10.1007/s10147-016-0989-6. Epub 2016 May 26. Int J Clin Oncol. 2016. PMID: 27230992
-
Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.Clin Oral Investig. 2014 Jan;18(1):189-97. doi: 10.1007/s00784-013-0936-0. Epub 2013 Feb 21. Clin Oral Investig. 2014. PMID: 23430338
-
Malignancy risk models for oral lesions.Med Oral Patol Oral Cir Bucal. 2013 Sep 1;18(5):e759-65. doi: 10.4317/medoral.18374. Med Oral Patol Oral Cir Bucal. 2013. PMID: 23722122 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical